ArticleCurrent pharmaceutical design2013

Lysosomal rerouting of Hsp70 trafficking as a potential immune activating tool for targeting melanoma.

Kata Juhász et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.